Items where authors include "Sydes, M.R."

Number of items: 11.

Article

Parker, C.C. orcid.org/0000-0001-6512-124X, Petersen, P.M., Cook, A.D. orcid.org/0000-0003-4417-2632 et al. (55 more authors) (2024) Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047). Annals of Oncology, 35 (7). pp. 656-666. ISSN 0923-7534

Sydes, M.R., Murray, M.L., Ahmed, S. et al. (25 more authors) (2024) Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials. Contemporary Clinical Trials, 141. 107514. ISSN 1551-7144

Toader, A.-M. orcid.org/0000-0002-3801-3486, Campbell, M.K., Quint, J.K. et al. (32 more authors) (2024) Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage. Trials, 25 (1). 94. ISSN 1745-6215

Mitchell, E.J. orcid.org/0000-0002-6998-4533, Appelbe, D. orcid.org/0000-0003-1493-0391, Bravery, A. orcid.org/0000-0001-5415-0037 et al. (9 more authors) (2023) e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidence. Trials, 24 (1). 657. ISSN 1745-6215

Wason, J.M.S., Dimairo, M., Biggs, K. et al. (16 more authors) (2022) Practical guidance for planning resources required to support publicly-funded adaptive clinical trials. BMC Medicine, 20 (1). 254.

Parker, C.C., James, N.D. orcid.org/0000-0002-7314-8204, Brawley, C.D. orcid.org/0000-0003-3641-278X et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Wilson, N., Biggs, K., Bowden, S. et al. (19 more authors) (2021) Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project. BMC Medicine, 19 (1). 251. ISSN 1741-7015

Sydes, M.R., Barbachano, Y., Bowman, L. et al. (25 more authors) (2021) Realising the full potential of data-enabled trials in the UK : a call for action. BMJ Open, 11 (6). e043906. ISSN 2044-6055

Clarke, N.W., Ali, A., Ingleby, F.C. et al. (47 more authors) (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Annals of Oncology, 30 (12). pp. 1992-2003. ISSN 0923-7534

Pallmann, P., Bedding, A.W., Choodari-Oskooei, B. et al. (13 more authors) (2018) Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Medicine, 16 (29). ISSN 1741-7015

Proceedings Paper

Brown, J.E. orcid.org/0000-0003-4960-3032, Handforth, C., Walsh, J. orcid.org/0000-0002-7122-2650 et al. (5 more authors) (2019) 857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial. In: Annals of Oncology. 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain. Elsevier BV , v334-v335.

This list was generated on Thu Apr 3 06:43:45 2025 BST.